Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Qinetiq confident despite 'difficult' year, secures £1.5bn MoD deal

(Sharecast News) - Qinetiq posted a slide in profits on Thursday following a "difficult" year, but said it expected trading to improve, helped in part by a key defence contract worth more than £1.5bn. The defence and security specialist, which warned on profits earlier this year, posted a 2% uplift in underlying revenues for the year to 31 March to £1.93bn.

But operating profits fell to £185.4m from £215.2m, while earnings per share were down 11.2% at 26.1p.

On a reported basis, revenues ticked just 1% higher, while operating losses, weighed down by goodwill impairments and restructuring costs, came in at £90.5m, compared to profits of £192.5m a year previously.

The firm has been rocked by tough trading conditions in key markets, including UK intelligence, as well as heightened geopolitical uncertainty.

Steve Wadey, chief executive, said: "This has been a difficult year for the group, and while we recorded modest growth in revenue and generated good cashflow, our financial performance was not what we anticipated."

However, looking to the current year, and Wadey said the group now had a clear restructuring plan in place, which would help "strengthen and capture the increasing opportunities within our key markets".

It finished the year with the order intake 12% higher at £1.95bn, a record, "and continue to see strong demand for our mission-critical capabilities", including a major contract with the Ministry of Defence.

The five-year extension to its long term partnering agreement to modernise test and evaluation services for the MoD is worth £1.54bn, Qinetiq said.

Qinetiq forecast a 3% uplift in full-year 2026 revenues and EPS growth of between 15% and 20%. The margin was forecast to be around 11%.

Wadey said: "The fundamentals of our business are strong, our priority remains on delivering value accretive organic growth."

As at 0845 BST, shares in FTSE 250 stock were trading 4% higher at 458.4p.

Jamie Murray, analyst at Shore Capital, said: "While the [LTPA] renewal was widely expected, today's announcement should ease any concerns surrounding the contract. We will make minor adjustments to our model, but our forecasts remain broadly in line with guidance and we do not expect a material uplift."

Shore Cap has a 'hold' recommendation on the stock.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.